ホーム>>Signaling Pathways>> Tyrosine Kinase>> DYRK>>Protein kinase inhibitors 1 hydrochloride

Protein kinase inhibitors 1 hydrochloride

カタログ番号GC61217

プロテインキナーゼ阻害剤 1 塩酸塩は強力な HIPK2 阻害剤であり、HIPK1 および HIPK2 の IC50 は 136 および 74 nM、HIPK2 の Kd は 9.5 nM です。

Products are for research use only. Not for human use. We do not sell to patients.

Protein kinase inhibitors 1 hydrochloride 化学構造

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$101.00
在庫あり
5mg
$92.00
在庫あり
10mg
$162.00
在庫あり
25mg
$343.00
在庫あり
50mg
$612.00
在庫あり
100mg
$1,020.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com


顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Protein kinase inhibitors 1 hydrochloride is a potent HIPK2 inhibitor, with IC50s of 136 and 74 nM for HIPK1 and HIPK2, and a Kd of 9.5 nM for HIPK2.

Protein kinase inhibitors 1 hydrochloride is a potent HIPK2 inhibitor, with IC50s of 136 and 74 nM for HIPK1 and HIPK2, and a Kd of 9.5 nM for HIPK2. Protein kinase inhibitors 1 (Compound A64) is not an effective Cdk1 inhibitor (IC50 > 10 μM). A64 is moderately selective across a panel of kinases, with Kds of 3.7 nM (PIM3), 6.1 nM (CSNK2A2), 6.1 nM (CSNK2A2), 8.8 nM (DYRK1A), 9.5 nM (DAPK1), 31 nM (CSNK2A1), 37 nM (PIM1), 130 nM (DRAK2), 150 nM (CLK2), 190 nM (DRAK1), 220 nM (ULK2), 240 nM (CLK1), 250 nM (DYRK2), and 390 nM (ERK8) and IC50s of 19 nM (DYRK1A), 62 nM (DYRK1B), and 74 nM (HIPK2)[1].

[1]. Miduturu CV, et al. High-throughput kinase profiling: a more efficient approach toward the discovery of new kinaseinhibitors. Chem Biol. 2011 Jul 29;18(7):868-79.

レビュー

Review for Protein kinase inhibitors 1 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Protein kinase inhibitors 1 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.